| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid and other current assets | 40,356 | |||
| Marketable securities | 432,088 | |||
| Cash and cash equivalents | 129,076 | |||
| Total current assets | 601,520 | |||
| Property and equipment, net | 77 | |||
| Other assets | 632 | |||
| Operating lease right-of-use assets | 1,256 | |||
| Total assets | 603,485 | |||
| Accrued expenses | 24,170 | |||
| Operating lease liabilities, current | 784 | |||
| Accounts payable | 14,657 | |||
| Total current liabilities | 39,611 | |||
| Other noncurrent liabilities | 5,306 | |||
| Operating lease liabilities, noncurrent | 679 | |||
| Term loan, noncurrent, net | 36,156 | |||
| Warrant liability | 0 | |||
| Total liabilities | 81,752 | |||
| Accumulated deficit | -1,007,290 | |||
| Common stock, 0.001 par value 200,000,000 shares authorized 148,304,875 and 119,849,436 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively | 148 | |||
| Additional paid-in capital | 1,528,753 | |||
| Accumulated other comprehensive income | 122 | |||
| Total stockholders equity | 521,733 | |||
| Total liabilities and stockholders equity | 603,485 | |||
89bio, Inc. (ETNB)
89bio, Inc. (ETNB)